These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31421908)

  • 1. Clinical Benefit of Empiric High-Dose Levofloxacin Therapy for Adults With Community-onset Enterobacteriaceae Bacteremia.
    Lee CC; Yang CY; Lee CH; Hsieh CC; Hong MY; Tang HJ; Ko WC
    Clin Ther; 2019 Oct; 41(10):1996-2007. PubMed ID: 31421908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the therapeutic efficacies of third-generation cephalosporins and broader-spectrum β-lactams as appropriate empirical therapy in adults with community-onset monomicrobial Enterobacteriaceae bacteraemia: a propensity score matched analysis.
    Lee CH; Hsieh CC; Hong MY; Hung YP; Ko WC; Lee CC
    Int J Antimicrob Agents; 2017 May; 49(5):617-623. PubMed ID: 28315452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of early empirical administration of appropriate antimicrobials on survival and defervescence in adults with community-onset bacteremia.
    Lee CC; Lee CH; Yang CY; Hsieh CC; Tang HJ; Ko WC
    Crit Care; 2019 Nov; 23(1):363. PubMed ID: 31747950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propensity score-matched analysis comparing the therapeutic efficacies of cefazolin and extended-spectrum cephalosporins as appropriate empirical therapy in adults with community-onset Escherichia coli, Klebsiella spp. and Proteus mirabilis bacteraemia.
    Hsieh CC; Lee CH; Hong MY; Hung YP; Lee NY; Ko WC; Lee CC
    Int J Antimicrob Agents; 2016 Dec; 48(6):712-718. PubMed ID: 27836382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Benefit of Appropriate Empirical Fluoroquinolone Therapy for Adults with Community-Onset Bacteremia in Comparison with Third-Generation-Cephalosporin Therapy.
    Lee CC; Wang JL; Lee CH; Hsieh CC; Hung YP; Hong MY; Tang HJ; Ko WC
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of 30-Day Mortality With Oral Step-Down vs Continued Intravenous Therapy in Patients Hospitalized With Enterobacteriaceae Bacteremia.
    Tamma PD; Conley AT; Cosgrove SE; Harris AD; Lautenbach E; Amoah J; Avdic E; Tolomeo P; Wise J; Subudhi S; Han JH;
    JAMA Intern Med; 2019 Mar; 179(3):316-323. PubMed ID: 30667477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-Related Trends in Adults with Community-Onset Bacteremia.
    Lee CC; Wang JL; Lee CH; Hung YP; Hong MY; Chang CM; Ko WC
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of gram-negative bacteremia during febrile neutropenia among allogeneic hematopoietic stem cell transplant recipients on levofloxacin prophylaxis.
    Ogura S; Kimura M; Takagi S; Mitsuki T; Yuasa M; Kageyama K; Kaji D; Nishida A; Taya Y; Ishiwata K; Yamamoto H; Asano-Mori Y; Yamamoto G; Uchida N; Wake A; Taniguchi S; Araoka H
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):941-948. PubMed ID: 33185742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of antimicrobial strategies on clinical outcomes of adults with septic shock and community-onset Enterobacteriaceae bacteremia: de-escalation is beneficial.
    Lee CC; Lee NY; Chen PL; Hong MY; Chan TY; Chi CH; Ko WC
    Diagn Microbiol Infect Dis; 2015 Jun; 82(2):158-64. PubMed ID: 25796557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial escalation is not beneficial for Gram-negative bacteremia in adults who remained critically ill after appropriate empirical therapy.
    Ho CY; Lee CH; Yang CY; Hsieh CC; Ko WC; Lee CC
    J Infect Chemother; 2020 Sep; 26(9):933-940. PubMed ID: 32386930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical benefits of antimicrobial de-escalation in adults with community-onset monomicrobial Escherichia coli, Klebsiella species and Proteus mirabilis bacteremia.
    Lee CC; Wang JL; Lee CH; Hung YP; Hong MY; Tang HJ; Ko WC
    Int J Antimicrob Agents; 2017 Sep; 50(3):371-376. PubMed ID: 28694235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empirical third-generation cephalosporin therapy for adults with community-onset Enterobacteriaceae bacteraemia: Impact of revised CLSI breakpoints.
    Hsieh CC; Lee CH; Li MC; Hong MY; Chi CH; Lee CC
    Int J Antimicrob Agents; 2016 Apr; 47(4):297-303. PubMed ID: 27005458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
    Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
    Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of appropriate empirical antimicrobial administration and outcome of adults with community-onset bacteremia.
    Lee CC; Lee CH; Hong MY; Tang HJ; Ko WC
    Crit Care; 2017 May; 21(1):119. PubMed ID: 28545484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of appropriateness of empiric therapy on outcomes in community-onset bacteremia by extended-spectrum-β-lactamase producing Escherichia coli and Klebisella pneumoniae definitively treated with carbapenems.
    Joo EJ; Park DA; Lee NR; Moon SY; Choi JK; Ko JH; Peck KR
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2093-2100. PubMed ID: 28643188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short versus long duration antimicrobial treatment for community-onset bacteraemia: A propensity score matching study.
    Lee CC; Hsieh CC; Yang CY; Hong MY; Lee CH; Tang HJ; Ko WC
    Int J Antimicrob Agents; 2019 Aug; 54(2):176-183. PubMed ID: 31108223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propensity score matched analysis comparing the clinical outcome of Klebsiella pneumoniae and Escherichia coli causing community-onset monomicrobial bacteremia.
    Kuo TH; Yang CY; Lee CH; Hsieh CC; Ko WC; Lee CC
    Medicine (Baltimore); 2017 Jun; 96(26):e7075. PubMed ID: 28658101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
    Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L
    Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propensity-matched analysis to compare the therapeutic efficacies of cefuroxime versus cefotaxime as initial antimicrobial therapy for community-onset complicated nonobstructive acute pyelonephritis due to Enterobacteriaceae infection in women.
    Chang UI; Kim HW; Wie SH
    Antimicrob Agents Chemother; 2015 May; 59(5):2488-95. PubMed ID: 25645837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empiric Monotherapy Versus Combination Therapy for Enterobacteriaceae Bacteremia in Children.
    Berkowitz NM; Spaeder MC; DeBiasi RL; Campos J; Singh N
    Pediatr Infect Dis J; 2015 Nov; 34(11):1203-6. PubMed ID: 26301498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.